Pricing
  1. US-listed companies
  2. Tonix Pharmaceuticals Holding Corp.
  3. Financials
  4. Cash from operations

Tonix Pharmaceuticals Holding Corp. (TNXP)

Market cap
$122.55M
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Dec 31, 2024-61-40.27%
Dec 31, 2023-102+4.03%
Dec 31, 2022-98+29.77%
Dec 31, 2021-76+55.58%
Dec 31, 2020-49+82.01%
Dec 31, 2019-27+39.50%
Dec 31, 2017-19-48.74%
Dec 31, 2016-37-12.26%
Dec 31, 2015-43+86.20%
Dec 31, 2014-23+168.17%
Dec 31, 2013-9+49.08%
Dec 31, 2012-6+116.60%
Dec 31, 2011-3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat